Targeted nanocarriers for cancer therapy
Porous silicon nanoparticles are very promising as a drug carrier thanks to their high porosity, biodegradability and biocompatibility. This project will explore the application of these nanocarriers to deliver chemo, gene and/or immune therapy to treat cancers using a range of preclinical cancer models including humanised tissue engineered cancer models that are highly predictive of performance in the clinic.
Enhanced research experiences
Placements at QUT in Brisbane for the humanised cancer model are offered.